SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

29 Jul 2025 Evaluate
The June 2025 quarter revenue stood at Rs. 1633.64 millions, up 9.67% as compared to Rs. 1489.63 millions during the corresponding quarter last year.A humble growth in net profit of 8.41% reported in the quarter ended June 2025 to Rs. 210.54  millions from Rs. 194.21 millions.OP of the company witnessed a marginal growth to 433.61 millions from 335.83 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1633.64 1489.63 9.67 1633.64 1489.63 9.67 6672.05 6054.60 10.20
Other Income 105.93 68.41 54.85 105.93 68.41 54.85 362.16 335.01 8.10
PBIDT 433.61 335.83 29.12 433.61 335.83 29.12 1278.02 1406.68 -9.15
Interest 51.12 11.68 337.67 51.12 11.68 337.67 65.84 58.06 13.40
PBDT 382.49 324.15 18.00 382.49 324.15 18.00 1212.18 937.76 29.26
Depreciation 76.85 62.61 22.74 76.85 62.61 22.74 270.47 235.19 15.00
PBT 305.64 261.54 16.86 305.64 261.54 16.86 941.71 702.57 34.04
TAX 95.10 67.33 41.24 95.10 67.33 41.24 252.03 196.13 28.50
Deferred Tax -30.39 -2.95 930.17 -30.39 -2.95 930.17 -47.89 -75.49 -36.56
PAT 210.54 194.21 8.41 210.54 194.21 8.41 689.68 506.44 36.18
Equity 105.50 104.88 0.59 105.50 104.88 0.59 105.37 104.69 0.65
PBIDTM(%) 26.54 22.54 17.73 26.54 22.54 17.73 19.15 23.23 -17.55

Bliss GVS Pharma Share Price

258.65 4.35 (1.71%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×